---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-079360"
form_type: "8-K"
ticker: "NVCT"
cik: "0001875558"
company_name: "Nuvectis Pharma, Inc."
filed_at: "2026-06-30T20:43:15+00:00"
generated_at: "2026-06-30T20:44:05.974360+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nuvectis Pharma prices $100M public offering of 5M shares at $20.00 per share

## Summary
- Priced underwritten public offering of 5,000,000 shares at $20.00 per share for gross proceeds of $100 million.
- Net proceeds expected ~$93 million (or ~$107 million if underwriters' 30-day option for 750,000 additional shares is exercised).
- Offering expected to close on July 1, 2026; Cantor Fitzgerald acting as sole book-runner.
- Proceeds to fund development of NXP100, NXP200, NXP900 and for general corporate purposes.

## SEC filing metadata
- accession: 0001104659-26-079360
- form_type: 8-K
- ticker: NVCT
- cik: 0001875558
- company_name: Nuvectis Pharma, Inc.
- filed_at: 2026-06-30T20:43:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1875558/000110465926079360/0001104659-26-079360-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1875558/000110465926079360/tm2619346d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-079360
- JSON: https://secwatch.observer/filing/0001104659-26-079360.json
- Plain text: https://secwatch.observer/filing/0001104659-26-079360.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.